These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8484682)

  • 21. Drug metabolism by the gastrointestinal mucosa.
    George CF
    Clin Pharmacokinet; 1981; 6(4):259-74. PubMed ID: 6113909
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis.
    Taha AS; McLaughlin S; Holland PJ; Kelly RW; Sturrock RD; Russell RI
    Ann Rheum Dis; 1990 Jun; 49(6):354-8. PubMed ID: 2143369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of luminal acid on gastric and duodenal bicarbonate transport.
    Heylings JR; Hurst BC; Garner A
    Scand J Gastroenterol Suppl; 1984; 92():59-62. PubMed ID: 6610924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Efficacy and intolerance of meloxicam in injection and tablet form].
    Tiurin VP; Rakov AL
    Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute gastrointestinal permeability responses to different non-steroidal anti-inflammatory drugs.
    Smecuol E; Bai JC; Sugai E; Vazquez H; Niveloni S; Pedreira S; Mauriño E; Meddings J
    Gut; 2001 Nov; 49(5):650-5. PubMed ID: 11600467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The elderly patient: a special case.
    Seda H
    Scand J Rheumatol Suppl; 1989; 83():5-6. PubMed ID: 2626679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current status of treatment in rheumatic disorders (the newer generation of non-steroidal anti-inflammatory drugs).
    Gupta AK; Nand S; Nand S
    J Indian Med Assoc; 1991 Jul; 89(7):211-2. PubMed ID: 1940422
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipolytic activity in human intestinal mucosa.
    Vannini P; Gandolfi L; Frizziero G
    Panminerva Med; 1972 Nov; 14(11):365-8. PubMed ID: 4680903
    [No Abstract]   [Full Text] [Related]  

  • 29. Gastrointestinal disorders in rheumatic diseases.
    Parke AL
    Curr Opin Rheumatol; 1992 Feb; 4(1):68-75. PubMed ID: 1543665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conservative treatment of rheumatic disorders in the elderly.
    Mazanec DJ
    Geriatrics; 1991 May; 46(5):41-5. PubMed ID: 2029974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Lesion of the gastroduodenal mucosa caused by non-steroidal anti-inflammatory drugs (NSAID)].
    Pastor García E
    Aten Primaria; 1990 Jun; 7(6):448, 450-1. PubMed ID: 2129719
    [No Abstract]   [Full Text] [Related]  

  • 32. [Various aspects of the treatment with non-steroidal anti- inflammatory drugs].
    Gritsiuk AI; Angelutsa PA; Viktorov AP
    Revmatologiia (Mosk); 1989; (3):51-6. PubMed ID: 2609060
    [No Abstract]   [Full Text] [Related]  

  • 33. Nabumetone. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases.
    Friedel HA; Langtry HD; Buckley MM
    Drugs; 1993 Jan; 45(1):131-56. PubMed ID: 7680981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NSAIDs: a pain in the gut.
    Abraham P; Bhatia SJ
    J Assoc Physicians India; 1991 Dec; 39(12):915-7. PubMed ID: 1816215
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of nabumetone and indomethacin on gastric mucosal function.
    Shorrock CJ; Rees WD
    J Rheumatol Suppl; 1992 Nov; 36():85-8. PubMed ID: 1474543
    [No Abstract]   [Full Text] [Related]  

  • 36. How do non-steroidal anti-inflammatory drugs affect gastric mucosal defenses?
    Fromm D
    Clin Invest Med; 1987 May; 10(3):251-8. PubMed ID: 3304754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non steroidal anti-inflammatory drugs.
    Day RO
    Aust Fam Physician; 1987 Jun; 16(6):799, 803, 805 passim. PubMed ID: 3499886
    [No Abstract]   [Full Text] [Related]  

  • 38. Nitric oxide-releasing nonsteroidal anti-inflammatory drugs: gastrointestinal-sparing potential drugs.
    Singh R; Kumar R; Singh DP
    J Med Food; 2009 Feb; 12(1):208-18. PubMed ID: 19298218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome.
    Hanevik K; Dizdar V; Langeland N; Eide GE; Hausken T
    Aliment Pharmacol Ther; 2011 Jul; 34(2):259-60. PubMed ID: 21679211
    [No Abstract]   [Full Text] [Related]  

  • 40. Tempering the enthusiasm for COX-2 inhibitors.
    Nuovo J
    Am Fam Physician; 2000 Jun; 61(12):3560, 3563. PubMed ID: 10892630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.